Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
Philip Imus(Sidney Kimmel Cancer Center), Javier Bolaños‐Meade(Johns Hopkins University), Amanda L. Blackford(Johns Hopkins University), Leo Luznik(Johns Hopkins University), Maria Bettinotti(Johns Hopkins University), William Matsui(The University of Texas at Austin), Ivan Borrello(Tampa General Hospital), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Kenneth R. Cooke(Johns Hopkins University), August Dietrich(Sidney Kimmel Comprehensive Cancer Center), Ephraim J. Fuchs(Johns Hopkins University), Richard F. Ambinder(Johns Hopkins University), Noah Tucker(Johns Hopkins University), Robert A. Brodsky(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Brian Iglehart(Sidney Kimmel Comprehensive Cancer Center), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Heather J. Symons(Johns Hopkins University)
Cited by 59
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k